All In Biotech

Drug Trial Radar · NCT00009620

Antenatal Phenobarbital to Prevent Neonatal Intracranial Hemorrhage

Randomized Clinical Trial of Antenatal Phenobarbital in the Prevention of Neonatal Intracranial Hemorrhage

Last checked: Nov 19, 2026Latest source record: Mar 22, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 610 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

610

Actual

Start

Feb 1993

Primary completion

Feb 1995

Study completion Feb 1997

Sponsor

Lead sponsor
NICHD Neonatal Research NetworkResearch network
Sponsor type
Research network
Collaborators
National Center for Research Resources (NCRR)
First posted
Feb 5, 2001

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Prevention
Who can join
Female only
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This large randomized trial tested whether phenobarbital given to a pregnant woman about to deliver a premature infant would prevent brain injuries in their newborns. Women with 24 to 32 week fetuses who were in preterm labor and were expected to deliver within 24 hrs were randomized to phenobarbital or usual care. They were treated until they deliver or the fetus reaches 33 wks gestation. Babies were followed until discharge and evaluated at 18-22 mos corrected age for neurodevelopmental outcome.

Conditions

  • Infant, Newborn
  • Infant, Low Birth Weight
  • Infant, Small for Gestational Age
  • Infant, Premature
  • Intracranial Hemorrhages

Interventions

  • PhenobarbitalDrug

    10 mg of phenobarbital per kilogram of body weight intravenously over a period of 20 to 40 minutes (maximal dose, 1000 mg)

  • SalineDrug

    Infusion of normal sal

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Neonatal intracranial hemorrhage or deathTime frame: 72 hours of life

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Stanford University

    Palo Alto, California

  • Yale University

    New Haven, Connecticut

  • George Washington University

    Washington D.C., District of Columbia

  • Emory University

    Atlanta, Georgia

  • Indiana University

    Indianapolis, Indiana

  • Wayne State University

    Detroit, Michigan

  • University of New Mexico

    Albuquerque, New Mexico

  • Cincinnati Children's Medical Center

    Cincinnati, Ohio

  • Case Western Reserve University, Rainbow Babies and Children's Hospital

    Cleveland, Ohio

  • Brown University, Women & Infants Hospital of Rhode Island

    Providence, Rhode Island

  • University of Tennessee

    Memphis, Tennessee

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.